1. IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression
   Lei Ren et al, 2017, Molecular Immunology CrossRef
2. Intratumoral IL17-producing cells infiltration correlate with antitumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer
   J.T. Wang et al, 2019, Annals of Oncology CrossRef
3. IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population
   Wennan Wu et al, 2021, Infection, Genetics and Evolution CrossRef
4. IL-17 and VEGF are significantly associated with disease progression involving systemic inflammation in patients with gastric and colorectal cancers
   Kazuo Minamikawa et al, 2017, Annals of Cancer Research and Therapy CrossRef
5. The mechanisms of IL-17A on promoting tumor metastasis
   Ling-Ling Xu et al, 2017, International Reviews of Immunology CrossRef
6. The Trinity of Matrix Metalloproteinases, Inflammation, and Cancer: A Literature Review of Recent Updates
   Erva Ozkan et al, 2020, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry CrossRef
7. Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population
   Fei Zhou et al, 2016, Oncotarget CrossRef
8. Leukemic IL‐17RB signaling regulates leukemic survival and chemoresistance
   He‐Zhou Guo et al, 2019, The FASEB Journal CrossRef
9. Molecular Determinants of Peritoneal Dissemination in Gastric Adenocarcinoma
   Valentina Mari et al, 2023, Digestive Diseases CrossRef
10. The time-dependent prognostic value of intratumoral cytokine expression profiles in a natural course of primary breast cancer with a long-term follow-up
    Nataša Todorović-Raković et al, 2018, Cytokine CrossRef
11. The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review
    Simone Punt et al, 2015, OncoImmunology CrossRef
12. Lysophosphatidic Acid is a Biomarker for Peritoneal Carcinomatosis of Gastric Cancer and Correlates with Poor Prognosis
    Ruolan Zeng et al, 2017, Genetic Testing and Molecular Biomarkers CrossRef
13. Techniques of staging laparoscopy and peritoneal fluid assessment in gastric cancer: a systematic review
    Karol Rawicz-Pruszyński et al, 2023, International Journal of Surgery CrossRef
14. Clinical significance of Serum Pepsinogen I/II and gastrin-17 determination in gastric cancer diagnosis and prognosis
    Huiguang Xue et al, 2018, European Journal of Inflammation CrossRef
15. Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis
    Mathieu Pecqueux et al, 2015, Oncotarget CrossRef
16. Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers
    Yanyan Chen et al, 2020, Cancers CrossRef
17. Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis
    Francisco Tustumi et al, 2016, Clinics CrossRef
18. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer
    Xuan‐Yu Hu et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
19. Association ofIL-17polymorphisms with gastric cancer risk in Asian populations
    Zi-Wen Long, 2015, World Journal of Gastroenterology CrossRef
20. Effect of radiotherapy and chemotherapy on levels of serum S100B, IL-6, and IL-17 in patients with malignant glioma
    Chao Xiang et al, 2018, European Journal of Inflammation CrossRef
21. Molecular alterations of cancer cell and tumour microenvironment in metastatic gastric cancer
    Weilin Li et al, 2018, Oncogene CrossRef
22. The Role of Gastrokine 1 in Gastric Cancer
    Jung Hwan Yoon et al, 2014, Journal of Gastric Cancer CrossRef